alendronate and thyroxine

alendronate has been researched along with thyroxine in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (50.00)18.2507
2000's2 (33.33)29.6817
2010's1 (16.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Bauss, F; Bosies, E; Fleisch, H; Janner, M; Mühlbauer, RC; Schenk, R; Strein, K1
Balena, R; Gentile, M; Markatos, A; Masarachia, P; Rodan, GA; Seedor, JG; Yamamoto, M1
Affinito, P; Arlotta, F; Cascone, E; Di Carlo, C; Lupoli, G; Nappi, C; Nuzzo, V; Vitale, G; Vollery, M1
Gomez-Acotto, C; Mautalen, C; Zeni, S1
Assante, R; Fonderico, F; Lupoli, G; Lupoli, GA; Marciello, F; Martinelli, A; Panico, A1

Reviews

1 review(s) available for alendronate and thyroxine

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Other Studies

5 other study(ies) available for alendronate and thyroxine

ArticleYear
BM 21.0955, a potent new bisphosphonate to inhibit bone resorption.
    Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 1991, Volume: 6, Issue:9

    Topics: Alendronate; Animals; Benzoates; Bone Resorption; Calcium; Clodronic Acid; Diphosphonates; Etidronic Acid; Ibandronic Acid; Injections, Intravenous; Osteoclasts; Pamidronate; Rats; Retinoids; Risedronic Acid; Spectrophotometry, Atomic; Tetracycline; Thyroxine

1991
The effects of the aminobisphosphonate alendronate on thyroid hormone-induced osteopenia in rats.
    Calcified tissue international, 1993, Volume: 53, Issue:4

    Topics: Alendronate; Animals; Bone Diseases, Metabolic; Bone Remodeling; Bone Resorption; Diphosphonates; Disease Models, Animal; Hyperthyroidism; Male; Osteoclasts; Rats; Rats, Sprague-Dawley; Thyroxine; Tibia

1993
Effects of alendronate on bone loss in pre- and postmenopausal hyperthyroid women treated with methimazole.
    Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 1996, Volume: 10, Issue:5

    Topics: Adult; Alendronate; Bone Density; Female; Humans; Hyperthyroidism; Methimazole; Middle Aged; Osteocalcin; Osteoporosis, Postmenopausal; Thyrotropin; Thyroxine; Triiodothyronine

1996
Do different aminobisphosphonates have similar preventive effect on experimental thyroid hormone-induced osteopenia in rats?
    Calcified tissue international, 2001, Volume: 69, Issue:5

    Topics: Alendronate; Animals; Body Weight; Bone Diseases, Metabolic; Diphosphonates; Female; Pamidronate; Rats; Rats, Sprague-Dawley; Thyroxine

2001
Osteoporosis and thyrotropin-suppressive therapy: reduced effectiveness of alendronate.
    Thyroid : official journal of the American Thyroid Association, 2009, Volume: 19, Issue:5

    Topics: Adult; Alendronate; Antineoplastic Agents, Hormonal; Bone Density; Bone Density Conservation Agents; Calcium; Carcinoma; Case-Control Studies; Dietary Supplements; Drug Interactions; Female; Femur; Humans; Lumbar Vertebrae; Middle Aged; Osteoporosis, Postmenopausal; Radiography; Thyroid Neoplasms; Thyroxine; Time Factors; Treatment Outcome; Vitamin D

2009